XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Organization and Basis of Presentation (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 02, 2023
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Apr. 09, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Minimum net stockholders equity maintaining in nasdaq $ 2,500,000                  
Stockholders equity   $ 2,246,139 $ 2,692,534 $ 2,246,139 $ 2,692,534 $ 3,126,367 $ 3,994,762 $ 4,080,829 $ 5,165,227  
Net Income (Loss) Attributable to Parent   1,010,919 1,668,355 1,982,241 3,036,014          
Net Cash Provided by (Used in) Operating Activities       1,608,266 2,446,753          
Cash   2,595,222   2,595,222     4,203,488     $ 40,000
Clinical Trial Agreements And Clinical Trial Monitoring Agreements [Member]                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Contractual Obligation   3,614,000   3,614,000            
Common Stock [Member]                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Reverse stock split 1-for-10                  
Stockholders equity   225 166 225 166 $ 225 $ 225 $ 166 $ 166  
Net Income (Loss) Attributable to Parent            
Common Stock [Member] | Minimum [Member]                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                    
Bid price $ 1.00